Senseonics (SENS) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Senseonics (NYSEAMERICAN:SENS) released its earnings results on Tuesday. The company reported ($0.12) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.13) by $0.01, reports. Senseonics had a negative return on equity of 406.72% and a negative net margin of 828.76%. The firm had revenue of $2.90 million for the quarter, compared to the consensus estimate of $2.95 million. The firm’s revenue was up 866.7% on a year-over-year basis.

Senseonics (NYSEAMERICAN:SENS) opened at $3.07 on Wednesday. The company has a debt-to-equity ratio of 0.76, a current ratio of 2.93 and a quick ratio of 2.81. Senseonics has a 12-month low of $1.26 and a 12-month high of $3.67. The stock has a market capitalization of $413.30 and a price-to-earnings ratio of -6.14.

Separately, Canaccord Genuity reissued a “buy” rating on shares of Senseonics in a research report on Friday, March 2nd.

COPYRIGHT VIOLATION NOTICE: This report was published by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another site, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this report can be viewed at

About Senseonics

Senseonics Holdings, Inc is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes.

Earnings History for Senseonics (NYSEAMERICAN:SENS)

Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with's FREE daily email newsletter.

Leave a Reply